TVERDOFAZNAYa REAKTsIYa INGIBIROVANIYa SIALIDAZNOY AKTIVNOSTI DLYa OPREDELENIYa ANTITEL K NEYRAMINIDAZE VIRUSA GRIPPA PRI INFEKTsII I VAKTsINATsII

Cite item

Full Text

Open Access
Restricted Access

Access granted
Restricted Access

Subscription or Fee Access

Marcelin G., Bland H. M., Negovetich N.J. et al. Inactivated seasonal influenza vaccines increase serum antibodies to the neuraminidase of pandemic influenza A(H1N1) 2009 virus in an age-dependent manner // The Journal of Infectious Diseases.- 2010.- Vol. 202, № 11.-P. 1634-1638.
Sandbulte M. R., Jimenez G. S., Boon A. C. et al. Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans // PLoS medicine.- 2007.- Vol. 4, № 2.- P. 265-272.
World Health Organization. WHO Manual on Animal Influenza Diagnosis and Surveillance 2002.5, Rev. 1 [Electronic resource] // WHO.-Access mode: http://www.who.int/csr/resources/publications/influenza/whocdscsrncs20025rev.pdf, free.
Lambre C. R, Terzidis H., Greffard A., Webster R. G. Measurement of anti-influenza neuraminidase antibody using a peroxidase-linked lectin and microtitre plates coated with natural substrates // Journal of immunological methods.- 1990.- Vol. 135.- P. 49-57.

Supplementary Files

Action

1. JATS XML